ORIGINAL RESEARCH
Accepted on 11 Aug 2025
Efficacy and Safety of the S-1, nab-Paclitaxel, and Gemcitabine Triplet Regimen in Patients with Resected Pancreatic Ductal Adenocarcinoma(PDAC)
doi 10.3389/fonc.2025.1622215
912
Total downloads
5,959
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
ORIGINAL RESEARCH
Accepted on 11 Aug 2025
CASE REPORT
Accepted on 01 Aug 2025
ORIGINAL RESEARCH
Published on 01 Aug 2025
ORIGINAL RESEARCH
Published on 21 Jul 2025
CASE REPORT
Published on 18 Jul 2025
ORIGINAL RESEARCH
Published on 19 Jun 2025
ORIGINAL RESEARCH
Published on 18 Jun 2025
ORIGINAL RESEARCH
Published on 13 Jun 2025
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: